摘要
３５例高血压、冠心病及高血压合并脑血管病患者进行量子血疗，对治疗前后红细胞抗氧化酶比活性、血浆脂质过氧化物（ＬＰＯ）；血栓素Ｂ_２（ＴＸＢ_２）及６－酮前列腺素Ｆ_（１α）（６－Ｋｅｔｏ－ＰＧＦ_（１α））含量进行了比较，结果：２５例患者血压、心电图基本恢复正常或得到不同程度改善。治疗前后红细胞超氧化物歧化酶（ＳＯＤ）、谷胱甘肽过氧化物酶（ＧＳＨ－Ｐｘ）比活性及血浆ＬＰＯ水平均无显著性变化；而治疗后血浆ＴＸＢ_２含量显著性降低，６－Ｋｅｔｏ－ＰＧＦ_（１α）含量显著性升高。提示：量子血疗对患者体内脂质过氧化作用无明显影响，而对ＴＸＡ_２－ＰＧＩ_２平衡起到一定的调节作用。
cases of hypertension,coronary heart disease or hypertension accompanied cardiovascular disease were treated with UBI,and the specific activity of antioxidases in erythrocytes,the LPO,TXB_2 and 6-Keto-PGF_(1α) levels in the plasma of patients before and after UBI treatment were determined. The results showed that of the 35 cases,25 recovered or improved clinical symptoms.Blood pressure or electrocardiogram,and the specific activity of SOD or GSH-px in erythrocyte,LPO levels in plasma had no significant changes.However,the TXB_2 level significantly decreased,and the 6-Keto-PGF_(1α)level significantly increased after the treatment.This suggested that the UBI might have no effect on lipid peroxidation,but have a regulation effect on the TXA_2-PGI_2 balance in patients.
出处
《河南医科大学学报》
1996年第2期89-91,共3页
Journal of Henan Medical University
